Increased expression but not targeting of ENaC in adrenalectomized rats with PAN-induced nephrotic syndrome.
Sodium retention is a hallmark of nephrotic syndrome (NS). Puromycin aminonucleoside (PAN)-induced NS is associated with high aldosterone levels and increased ENaC expression and apical targeting. However, the mechanisms associated with increased apical targeting of ENaC in NS remain undefined, and it is unclear whether this is secondary to high aldosterone levels and whether aldosterone and/or apical ENaC targeting are important for the development of sodium retention. This study aimed at uncovering 1) whether aldosterone is essential for sodium retention in PAN-induced NS, 2) whether ENaC expression or apical targeting is secondary to high aldosterone levels, and 3) the role of aldosterone in the dysregulation of sodium transporters in NS. Puromycin treatment of adrenalectomized (ADX) rats supplemented with dexamethasone induced sodium retention despite the absence of aldosterone. Immunocytochemical analyses revealed an absence of enhanced apical targeting of ENaC subunits in PAN-treated ADX (ADX-PAN) rats, with distribution of labeling similar to adrenalectomized dexamethasone-treated control rats (ADX). Moreover, ENaC subunit abundance was increased in ADX-PAN rats. The abundance of aquaporin-2 was unchanged, whereas apical targeting was enhanced. Key sodium transporters were downregulated as previously observed in nonadrenalectomized puromycin-treated rats (Kim SW, Wang W, Nielsen J, Praetorius J, Kwon TH, Knepper MA, Frøkiaer J, and Nielsen S. Am J Physiol Renal Physiol 286: F922-F935, 2004), whereas the global expression of the alpha1-subunit of the Na-K-ATPase was unchanged. In conclusion, PAN treatment in the absence of aldosterone induced sodium retention, increased ENaC expression, but did not change the subcellular distribution of ENaC. This indicates that the previously observed enhanced apical targeting of ENaC in PAN-induced NS (Kim SW, Wang W, Nielsen J, Praetorius J, Kwon TH, Knepper MA, Frøkiaer J, and Nielsen S. Am J Physiol Renal Physiol 286: F922-F935, 2004) is caused by aldosterone and that development of sodium retention can occur in the absence of aldosterone in NS.
de Seigneux
Sophie
S
The Water and Salt Research Center, Bldg. 233/234, University of Aarhus, and Institute of Clinical Medicine, Aarhus University Hospital, Denmark.
Kim
Soo Wan
SW
Hemmingsen
Sophie C
SC
Frøkiaer
Jørgen
J
Nielsen
Søren
S
D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2 / Q000032:analysis; D000315:Adrenalectomy; D000450:Aldosterone / Q000502:physiology*; D000818:Animals; D051399:Aquaporin 2 / Q000032:analysis / Q000502:physiology; D003907:Dexamethasone / Q000494:pharmacology; D015536:Down-Regulation; D053503:Epithelial Sodium Channels; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology*; D007150:Immunohistochemistry; D007668:Kidney / Q000737:chemistry* / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D008297:Male; D009404:Nephrotic Syndrome / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology* / Q000652:urine; D011188:Potassium / Q000652:urine; D011692:Puromycin Aminonucleoside; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium / Q000652:urine; D015222:Sodium Channels / Q000032:analysis* / Q000187:drug effects / Q000235:genetics* / Q000502:physiology
D051399:Aquaporin 2; D053503:Epithelial Sodium Channels; D015222:Sodium Channels; D000450:Aldosterone; D011692:Puromycin Aminonucleoside; D003907:Dexamethasone; D012964:Sodium; D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2; D011188:Potassium